AFFERENT PHARMACEUTICALS INC has a total of 67 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are RIGGS-SAUTHIER JENNIFER, VERSI GROUP LLC and BIOLAB SANUS FARMACÊUTICA LTDA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Australia | 5 | |
#5 | Canada | 5 | |
#6 | Republic of Korea | 5 | |
#7 | Mexico | 5 | |
#8 | China | 4 | |
#9 | Brazil | 3 | |
#10 | Chile | 3 | |
#11 | Costa Rica | 1 | |
#12 | Hong Kong | 1 | |
#13 | Israel | 1 | |
#14 | Japan | 1 | |
#15 | Nicaragua | 1 | |
#16 | New Zealand | 1 | |
#17 | Peru | 1 | |
#18 | Philippines | 1 | |
#19 | Russian Federation | 1 | |
#20 | Singapore | 1 | |
#21 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Ford Anthony P | 52 |
#2 | Hawley Ronald Charles | 26 |
#3 | Ibrahim Prabha | 26 |
#4 | Mccarthy Bruce G | 19 |
#5 | Gever Joel R | 17 |
#6 | Anthony P Ford | 10 |
#7 | Smith Steven | 7 |
#8 | Smith Steven A | 6 |
#9 | Prabha Ibrahim | 6 |
#10 | Ronald Charles Hawley | 6 |
Publication | Filing date | Title |
---|---|---|
KR20190097029A | Crystalline Salts and Polymorphs of P2X3 Antagonists | |
US2020239451A1 | Substituted pyrazole-pyrimidines, variants thereof, and uses therefore | |
KR20180128015A | Pyrimidine and its variants, and uses thereof | |
MX2018011136A | Pyrimidines and variants thereof, and uses therefor. | |
KR20180054843A | Diaminopyrimidine P2X3 and P2X2 / 3 receptor modulators for use in cough therapy | |
US2017151241A1 | Methods and compositions for treating diseases and conditions | |
WO2015027212A1 | Diaminopyrimidine p2x3 and p2x 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough |